24-Week Water Aerobics Program for Adults and Older Adults at Different Intensity Levels

July 28, 2024 updated by: Luís Oliveira Brandão Faíl, University of Beira Interior

The Role of Exercise Intensity in Water Aerobics: Improving Health Markers in Adults and Older Adults Over 24 Weeks

This goal of this clinical trial is to verify the best way to do water aerobics with adults and older adults. It wants to answer these questions:

  • Is high-intensity water aerobics better than water aerobics performed at moderate intensity?
  • Does a 24-week water aerobics program improve muscle strength, body weight, fat mass, triglycerides, cholesterol, blood pressure, and quality of life for adults and older adults?

Participants must:

  • Do water aerobics at high or moderate intensity, twice a week for 45 minutes per class, for 24 weeks.
  • Be assessed before starting the water aerobics program and after it ends to see if there are gains in muscle strength, body weight, fat mass, triglycerides, cholesterol, blood pressure, and quality of life.

It was believed that all variables would get better after doing water aerobics, no matter the intensity. It was also expected that doing higher-intensity water aerobics would lead to larger gains in all measurements compared to moderate-intensity.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Abrantes, Portugal, 2205-700
        • Tramagal Municipal Swimming Pool

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least 18 years of age

Exclusion Criteria:

  • taking part in another physical exercise program
  • being recently hospitalized
  • having severe motor or cognitive problems
  • having any medical restrictions on physical exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Moderate-intensity Group
Participants engaged in 45-minute water aerobics sessions twice a week for 24 weeks at moderate intensities.
In water aerobics sessions, the exercises are performed at a moderate intensity, between 60% and 70% of the participant's maximum heart rate predicted by their age.
Experimental: High-intensity Group
Participants engaged in 45-minute water aerobics sessions twice a week for 24 weeks at high intensities.
In water aerobics sessions, the exercises are performed at a high intensity, between 80% and 90% of the participant's maximum heart rate predicted by their age.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in explosive strength of lower limbs at 24 weeks
Time Frame: Baseline and week 25
The countermovement jump was used to assess the explosive strength of the lower limbs. Participants were instructed to perform three countermovement jumps, aiming to jump as high as possible, with one minute of rest between each jump. A higher jump height indicates a better score in this evaluation. The mean value of the three jumps was considered for the test.
Baseline and week 25
Change from Baseline in explosive strength of upper limbs at 24 weeks
Time Frame: Baseline and week 25
The explosive strength of the upper limbs was measured by having participants throw a 3-kilogram medicine ball, with the best scores achieved by throwing the ball as far as possible. Three throws were performed, and the mean value was used in this test.
Baseline and week 25
Change from Baseline in endurance strength of lower limbs at 24 weeks
Time Frame: Baseline and week 25
The chair stand test was used to evaluate the endurance strength of the lower limbs. Participants sat in the center of a chair with a straight back and feet shoulder-width apart and in full contact with the floor. They then rose to maximum extension and returned to the initial sitting position, aiming to complete as many repetitions as possible within a 30-second.
Baseline and week 25
Change from Baseline in endurance strength of upper limbs at 24 weeks
Time Frame: Baseline and week 25
The arm curl test assessed the upper limbs' endurance strength. Participants were seated in a chair with a straight back and their feet flat on the floor, holding a 2 kg dumbbell in their dominant hand. They were instructed to perform as many correct flexions as possible within a 30-second time limit.
Baseline and week 25
Change from Baseline in body mass at 24 weeks
Time Frame: Baseline and week 25
A bioimpedance balance was used for this test, with participants being barefoot and dressed in minimal clothing.
Baseline and week 25
Change from Baseline in fat mass percentage at 24 weeks
Time Frame: Baseline and week 25
Baseline and week 25
Change from Baseline in fat-free mass at 24 weeks
Time Frame: Baseline and week 25
Baseline and week 25
Change from Baseline in body mass index at 24 weeks
Time Frame: Baseline and week 25
The body mass index (BMI) was calculated by dividing the body mass value by the height squared (kg/m^2). For this, each participant's height was measured using a precision stadiometer with a scale of 0.001 m. For the correct extraction of this test, participants were barefoot.
Baseline and week 25
Change from Baseline in triglycerides at 24 weeks
Time Frame: Baseline and week 25
Blood samples were collected before exercise (after a 15-minute rest period) and at least 2 hours after the last meal.
Baseline and week 25
Change from Baseline in total cholesterol at 24 weeks
Time Frame: Baseline and week 25
Baseline and week 25
Change from Baseline in diastolic blood pressure at 24 weeks
Time Frame: Baseline and week 25
The automatic blood pressure monitor was used to measure the participants' blood pressure after seated and rested for 20 minutes.
Baseline and week 25
Change from Baseline in systolic blood pressure at 24 weeks
Time Frame: Baseline and week 25
Baseline and week 25
Change from Baseline in resting heart rate at 24 weeks
Time Frame: Baseline and week 25
Resting heart rate was assessed using an automatic blood pressure monitor, after the participant was seated and resting for at least 20 minutes.
Baseline and week 25

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in quality of life at 24 weeks
Time Frame: Baseline and week 25
The WHOQOL-BREF (Portuguese version) questionnaire, consisting of 26 items, was used to evaluate the participants' quality of life. Of the 26 items, 2 pertain to general quality of life and general health, while the remaining 24 items assess the perception of quality of life in 4 domains: physical, psychological, social relationships, and environment. Higher scores indicate a higher quality of life in each domain.
Baseline and week 25

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luís Faíl, University of Beira Interior

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2023

Primary Completion (Actual)

July 21, 2023

Study Completion (Actual)

July 28, 2023

Study Registration Dates

First Submitted

July 15, 2024

First Submitted That Met QC Criteria

July 28, 2024

First Posted (Actual)

July 31, 2024

Study Record Updates

Last Update Posted (Actual)

July 31, 2024

Last Update Submitted That Met QC Criteria

July 28, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CE-UBI-Pj-2019-051

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Moderate-intensity Group

Subscribe